Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Decitabine”

422 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 422 results

Testing effectiveness (Phase 2)Study completedNCT00042003
What this trial is testing

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

Who this might be right for
Chronic Myelogenous Leukemia
Astex Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)UnknownNCT05137886
What this trial is testing

PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma

Who this might be right for
Hodgkin Lymphoma, AdultRelapseRefractory Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 47
Early research (Phase 1)Not Yet RecruitingNCT07814339
What this trial is testing

Hydrochloroquinine & Decitabine With Venetoclax in AML

Who this might be right for
Acute Myeloid Leukemia
Rutgers, The State University of New Jersey 18
Early research (Phase 1)Study completedNCT00941109
What this trial is testing

Escalation Study to Determine Bioavailability of a Single Oral Dose of Decitabine in Patients With Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndrome
Eisai Inc. 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04763928
What this trial is testing

Trial in AML Secondary to MPNs Patients, Unfit for Intensive Chemotherapy, Investigating a Treatment Combination Including Decitabine and Venetoclax

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 101
Testing effectiveness (Phase 2)Ended earlyNCT00740181
What this trial is testing

Decitabine, Cytarabine, GCSF for Refractory AML/MDS

Who this might be right for
MyelodysplasiaLeukemia
Brown University 9
Testing effectiveness (Phase 2)Looking for participantsNCT03661307
What this trial is testing

Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia+2 more
M.D. Anderson Cancer Center 73
Testing effectiveness (Phase 2)Looking for participantsNCT06393361
What this trial is testing

Chidamide Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant.

Who this might be right for
Ineligible Or Refused Transplant Patients With Classical Hodgkin Lymphoma
Chinese PLA General Hospital 100
Testing effectiveness (Phase 2)UnknownNCT05143125
What this trial is testing

Treatment of Malignant Tumors With NK Cell

Who this might be right for
Malignancy
Shenzhen University General Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT07507760
What this trial is testing

Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients

Who this might be right for
Acute Myeloid Leukemia With Gene Mutations
PETHEMA Foundation 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04975919
What this trial is testing

Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Biphenotypic LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Biphenotypic Leukemia+1 more
M.D. Anderson Cancer Center 20
Large-scale testing (Phase 3)Study completedNCT03306264
What this trial is testing

Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia
Astex Pharmaceuticals, Inc. 227
Early research (Phase 1)Ended earlyNCT04172844
What this trial is testing

Pevonedistat, Azacitidine (or Decitabine), and Venetoclax for the Treatment of Patients With Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous Leukemia
Medical College of Wisconsin 16
Testing effectiveness (Phase 2)Study completedNCT00882102
What this trial is testing

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 43
Testing effectiveness (Phase 2)UnknownNCT04233294
What this trial is testing

Addition of Chidamide to the Combination Treatment of Decitabine Plus Camrelizumab in Combination Treatment Resistant/Relapsed Patients With Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Chinese PLA General Hospital 100
Testing effectiveness (Phase 2)WithdrawnNCT04985656
What this trial is testing

Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes (MDS)
Takeda
Testing effectiveness (Phase 2)Active Not RecruitingNCT04817241
What this trial is testing

Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Looking for participantsNCT05184842
What this trial is testing

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Montefiore Medical Center 91
Testing effectiveness (Phase 2)Looking for participantsNCT06923488
What this trial is testing

Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
West Virginia University 26
Large-scale testing (Phase 3)UnknownNCT05264883
What this trial is testing

Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AML

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital with Nanjing Medical University 170
Next Page